| Zacks Company Profile for Avitar Inc. (AVTI : OTC) |
|
|
| |
| • Company Description |
| Avitar, Inc. (Avitar), through its wholly owned subsidiary Avitar Technologies, Inc. (ATI), develops, manufactures, markets and sells diagnostic test products and hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. The Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company's foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. The Company continues to have applications for its technologies in a variety of other medical/consumer markets. They include a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. Customers for these products include ArthroCare and National Aeronautics and Space Administration (NASA).
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.00 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: -0.48 |
| 52 Week High: $ |
| 52 Week Low: $ |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
% |
% |
| 12 Week |
% |
% |
| Year To Date |
% |
% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
65 DAN ROAD
-
CANTON,MA 02021
USA |
ph: 781-821-2440
fax: 1-781-821-4458 |
None |
http://www.avitarinc.com |
|
|
| |
| • General Corporate Information |
Officers
Peter P. Phildius - Chairman of the Board and Chief Executive Officer
Douglas W. Scott - President and Chief Operating Officer and Director
J.C. Leatherman, Jr - Chief Financial Officer and Secretary
Neil R .Gordon - Director
Charles R. McCarthy - Director
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 053801304
SIC: 3842
|
|
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 2.00 (0.02:1)
Beta: -0.48
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
